HLA-C and neoplasm: These factors encompass the tumor mutational burden, the expression of major histocompatibility complex (MHC) and immune checkpoint molecules, as well as the infiltration of tumor-specific cytotoxic T lymphocytes and regulatory T cells rather than focusing solely on the overall T cell population.